{"id":8433,"date":"2019-07-11T16:10:48","date_gmt":"2019-07-11T20:10:48","guid":{"rendered":"https:\/\/www.silverlaw.com\/blog\/?p=8433"},"modified":"2019-07-11T16:10:48","modified_gmt":"2019-07-11T20:10:48","slug":"oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws","status":"publish","type":"post","link":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/","title":{"rendered":"Oasmia Pharmaceutical AB (OASM) Being Investigated For Potential Violations Of Securities Laws"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-8434 size-medium\" src=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3-300x200.jpg\" alt=\"Oasmia Pharmaceutical AB (OASM), a publicly-traded company that develops, manufactures, and sells cancer-treating drugs, is being investigated for potential violations of federal securities laws. After market close on July 9, 2019, Oasmia announced that it had terminated its \u201cengagement and cooperation\u201d agreement with former executive chairman Julian Aleksov after a tax audit revealed missing money related to suspicious transactions between Oasmia and companies controlled by Aleksov and his former father-in-law.\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3.jpg 300w, https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3-180x120.jpg 180w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>Oasmia Pharmaceutical AB (OASM), a publicly-traded company that develops, manufactures, and sells cancer-treating drugs, is being investigated for potential violations of federal securities laws.<\/p>\n<h3><strong>Oasmia Terminates Relationship With Executive Chairman<\/strong><\/h3>\n<p>After market close on July 9, 2019, Oasmia announced that it had terminated its \u201cengagement and cooperation\u201d agreement with former executive chairman Julian Aleksov after a tax audit revealed missing money related to suspicious transactions between Oasmia and companies controlled by Aleksov and his former father-in-law. <a href=\"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/#more-8433\" class=\"more-link\">Continue reading \u203a<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Oasmia Pharmaceutical AB (OASM), a publicly-traded company that develops, manufactures, and sells cancer-treating drugs, is being investigated for potential violations of federal securities laws. Oasmia Terminates Relationship With Executive Chairman After market close on July 9, 2019, Oasmia announced that it had terminated its \u201cengagement and cooperation\u201d agreement with former executive chairman Julian Aleksov after [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[602,1646],"tags":[],"class_list":["post-8433","post","type-post","status-publish","format-standard","hentry","category-class-action","category-securities-fraud"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oasmia Pharmaceutical AB (OASM) Being Investigated For Potential Violations Of Securities Laws<\/title>\n<meta name=\"description\" content=\"Oasmia Pharmaceutical AB (OASM), a publicly-traded company that develops cancer-treating drugs, is being investigated for violations of securities laws.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Oasmia Pharmaceutical AB (OASM) Being Investigated For Potential Violations Of Securities Laws\" \/>\n<meta name=\"twitter:description\" content=\"Oasmia Pharmaceutical AB (OASM), a publicly-traded company that develops cancer-treating drugs, is being investigated for violations of securities laws.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silver Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oasmia Pharmaceutical AB (OASM) Being Investigated For Potential Violations Of Securities Laws","description":"Oasmia Pharmaceutical AB (OASM), a publicly-traded company that develops cancer-treating drugs, is being investigated for violations of securities laws.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/","twitter_card":"summary_large_image","twitter_title":"Oasmia Pharmaceutical AB (OASM) Being Investigated For Potential Violations Of Securities Laws","twitter_description":"Oasmia Pharmaceutical AB (OASM), a publicly-traded company that develops cancer-treating drugs, is being investigated for violations of securities laws.","twitter_image":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3.jpg","twitter_misc":{"Written by":"Silver Law Group","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/#article","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/"},"author":{"name":"Silver Law Group","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"headline":"Oasmia Pharmaceutical AB (OASM) Being Investigated For Potential Violations Of Securities Laws","datePublished":"2019-07-11T20:10:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/"},"wordCount":237,"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3-300x200.jpg","articleSection":["Class Action","Securities Fraud"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/","url":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/","name":"Oasmia Pharmaceutical AB (OASM) Being Investigated For Potential Violations Of Securities Laws","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/#primaryimage"},"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3-300x200.jpg","datePublished":"2019-07-11T20:10:48+00:00","author":{"@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"description":"Oasmia Pharmaceutical AB (OASM), a publicly-traded company that develops cancer-treating drugs, is being investigated for violations of securities laws.","breadcrumb":{"@id":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/#primaryimage","url":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3.jpg","contentUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3.jpg","width":300,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/www.silverlaw.com\/blog\/oasmia-pharmaceutical-ab-oasm-being-investigated-for-potential-violations-of-securities-laws\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.silverlaw.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Oasmia Pharmaceutical AB (OASM) Being Investigated For Potential Violations Of Securities Laws"}]},{"@type":"WebSite","@id":"https:\/\/www.silverlaw.com\/blog\/#website","url":"https:\/\/www.silverlaw.com\/blog\/","name":"Securities Arbitration Lawyers Blog","description":"Published by Securities Arbitration Lawyers \u2014 Silver Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.silverlaw.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752","name":"Silver Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","caption":"Silver Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/8433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/comments?post=8433"}],"version-history":[{"count":2,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/8433\/revisions"}],"predecessor-version":[{"id":8436,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/8433\/revisions\/8436"}],"wp:attachment":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/media?parent=8433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/categories?post=8433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/tags?post=8433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}